Senior Investigator
Center for Health Research, Kaiser Permanente Northwest
Disclosure(s): AstraZeneca: Grant/Research Support; HilleVax: Grant/Research Support; Janssen: Grant/Research Support; Moderna: Grant/Research Support
Mark Schmidt, PhD, MPH, is an infectious disease epidemiologist with interdisciplinary training in molecular epidemiology and complex systems.
Dr. Schmidt’s primary research portfolio currently includes studies of acute gastroenteritis (including norovirus and C. difficile) and respiratory infection (including hMPV, RSV, and SARS-CoV-2). He is also the site PI for the Connect for Cancer Prevention NCI-sponsored cohort study and the FibrOtic Liver Disease (FOLD) consortium. Previous research includes: vaccine effectiveness, chronic hepatitis B and C viral infection, extraintestinal E. coli disease, and HIV Pre-Exposure Prophylaxis.
Dr. Schmidt is a Senior Investigator and the Kaiser Permanente Center for Health Research (CHR) in Portland, OR. He has worked at CHR since 2009. Prior to this, he worked for 10 years for the Oregon and Michigan state health departments, focusing on HIV/AIDS and communicable disease surveillance, outbreak investigation, bioterrorism preparedness, and pandemic influenza planning. He received his BS in biochemistry, MPH in hospital and molecular epidemiology, and PhD in epidemiologic science from the University of Michigan.